Article · 25 Feb 2026
Conference abstract
Phenotypic and functional assessment of peripheral blood dendritic cells in HIV/HCV co-infected patients undergoing Interferon/Ribavirin combination therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
H IV/HCV co-infection represents a significant burden on global economy and public health. It is now widely accepted that HIV accelerates the course of HCV-related chronic liver disease. The current standard treatment for treating HCV infection in HIV/HCV co-infected patients is a combination of pegylated interferon (IFN) and an antiviral drug ribavirin (RBV). This treatment is successful in only 50% of the patients and is associated with significant side effects. Therefore, it becomes necessary to determine the predictive host factors of successful treatment response. Since dendritic cells (DCs) play an important role in orchestrating innate and adaptive immune response against pathogens, we hereby investigate DC-based markers of treatment response to the combination therapy in a cohort of HIV-1/HCV co-infected individuals including non-responders (NRs), sustained virological responders (SVRs) and relapsers. Using a recently developed 13-color polychromatic DC antibody cocktail, mononuclear cells from patients isolated at different time points (baseline, week 1, 2, 4, 24 and 48) during the course of therapy were analyzed for various markers of myeloid and plasmacytoid DCs. We studied the frequency of mDCs (Lin-1 - /CD11c + CD123 - ) and pDCs (Lin-1 - /CD11c - CD123 + ) as well as markers of DC activation (HLA-ABC, HLA-DR, and CD86) and adhesion (CD54 and CD62L). We also analyzed chemokine receptors (CCR5 and CCR7), HIV entry receptor CD4 and death receptor ligand (PDL)-1 on DCs. Statistical analyses of data revealed CD62L and CCR7 to be potential markers of early treatment response. Ongoing studies involve transcriptomics and proteomics analysis of differential response between SVRs and NRs, which is likely to contribute towards effective therapeutic management of HIV-1/HCV co-infection
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of AIDS & Clinical Research.
Article · 22 Feb 2026
Drug Resistance and Quality of Life and their Associated Factors for HIV Patients under Treatment at the Second Line Regimens in Public Hospitals in Amhara Region, North-West Ethiopia
Article · 22 Feb 2026
Assessment of Public Knowledge, Attitude and Practices (KAP) and its Predictors towards Rabies Disease among Rural Households in North Wollo Zone, Ethiopia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of AIDS & Clinical Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Sehgal”
- BylineArticles whose byline prints “Zafar K. Khan”
- BylineArticles whose byline prints “Matt Chomo”
- BylineArticles whose byline prints “Renold Capocasale”
- BylineArticles whose byline prints “Andrew H. Talal”
- BylineArticles whose byline prints “Pooja Jain”
